Brazil drug distributors under financial strain: Elfa sold, Viveo raising capital, Oncoprod seeks credit

Brazil's three largest drug distributors are under financial pressure: Patria sold Elfa for R$620 million, Viveo is raising ~R$900 million via capital increase to cut leverage, and Oncoprod is seeking R$1.2 billion credit from Oncoclínicas, which is in extrajudicial recovery. This signals sector-wide distress, likely due to high debt and tight margins. The moves indicate consolidation and deleveraging, with potential implications for healthcare supply chains and credit markets.